Sinocare

Sinocare Inc. is a high-tech medical device company founded in 2002 and based in Changsha, Hunan Province, China. The company specializes in blood glucose monitoring products and chronic disease management solutions, aiming to ensure that every diabetic in China has access to a blood glucose meter. Sinocare holds a leading position in the Chinese market, with over 50% of diabetics using its products, and ranks No. 1 in China and No. 4 globally in the blood glucose monitoring sector. The product portfolio includes blood glucose meters, test strips, uric acid testing devices, continuous glucose monitoring systems, and digital health solutions that integrate biosensing technology and IoT. Sinocare operates seven research and development centers and eight production bases worldwide, reflecting its commitment to innovation. The company serves over 25 million users across 135 countries, catering to individuals with diabetes, healthcare providers, and institutions. Sinocare is publicly listed on the Shenzhen Stock Exchange and has received multiple awards for its technological advancements and contributions to the industry.

• Employees 30
• Founded 2002